Immunology and immunotherapy of colorectal cancer

Piero Dalerba, Cristina Maccalli, Chiara Casati, Chiara Castelli, Giorgio Parmiani

Research output: Contribution to journalArticle

Abstract

This review critically discusses data on immunology of colorectal cancer, starting from pathology and molecular biology, and then considering the molecular characterisation of colon cancer antigens and the clinical trials of immunotherapy. A careful evaluation of histopathological studies on intra-epithelial infiltration by T cells in primary tumours, together with the analysis of HLA expression by colorectal cancer cells, suggest that anti-tumour T cell immune responses may take place in vivo in those patients, influencing prognosis and shaping the tumour immunological profile. Moreover, the molecular characterisation of tumour antigens expressed by colorectal carcinomas, together with improved understanding of mechanisms of the immune response and more sensitive methods for the in vivo detection of T cell responses, are now allowing researchers to design new and more effective vaccination protocols, with encouraging preliminary results. By drawing together the experimental evidence from different research fields, this review provides support for the concept that colorectal carcinoma is immunogenic and may reasonably be considered as a target for immunotherapy, and attempts to address critical issues and envisage future developments in this challenging research field.

Original languageEnglish
Pages (from-to)33-57
Number of pages25
JournalCritical Reviews in Oncology/Hematology
Volume46
Issue number1
DOIs
Publication statusPublished - Apr 1 2003

Fingerprint

Allergy and Immunology
Immunotherapy
Colorectal Neoplasms
T-Lymphocytes
Neoplasms
Neoplasm Antigens
Research
Colonic Neoplasms
Molecular Biology
Vaccination
Research Personnel
Clinical Trials
Pathology
Antigens

Keywords

  • Colorectal cancer
  • Immunotherapy
  • T cells
  • Tumour antigens
  • Tumour vaccines

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Immunology and immunotherapy of colorectal cancer. / Dalerba, Piero; Maccalli, Cristina; Casati, Chiara; Castelli, Chiara; Parmiani, Giorgio.

In: Critical Reviews in Oncology/Hematology, Vol. 46, No. 1, 01.04.2003, p. 33-57.

Research output: Contribution to journalArticle

Dalerba, Piero ; Maccalli, Cristina ; Casati, Chiara ; Castelli, Chiara ; Parmiani, Giorgio. / Immunology and immunotherapy of colorectal cancer. In: Critical Reviews in Oncology/Hematology. 2003 ; Vol. 46, No. 1. pp. 33-57.
@article{fb2118b036ba493aa04fca46829388c7,
title = "Immunology and immunotherapy of colorectal cancer",
abstract = "This review critically discusses data on immunology of colorectal cancer, starting from pathology and molecular biology, and then considering the molecular characterisation of colon cancer antigens and the clinical trials of immunotherapy. A careful evaluation of histopathological studies on intra-epithelial infiltration by T cells in primary tumours, together with the analysis of HLA expression by colorectal cancer cells, suggest that anti-tumour T cell immune responses may take place in vivo in those patients, influencing prognosis and shaping the tumour immunological profile. Moreover, the molecular characterisation of tumour antigens expressed by colorectal carcinomas, together with improved understanding of mechanisms of the immune response and more sensitive methods for the in vivo detection of T cell responses, are now allowing researchers to design new and more effective vaccination protocols, with encouraging preliminary results. By drawing together the experimental evidence from different research fields, this review provides support for the concept that colorectal carcinoma is immunogenic and may reasonably be considered as a target for immunotherapy, and attempts to address critical issues and envisage future developments in this challenging research field.",
keywords = "Colorectal cancer, Immunotherapy, T cells, Tumour antigens, Tumour vaccines",
author = "Piero Dalerba and Cristina Maccalli and Chiara Casati and Chiara Castelli and Giorgio Parmiani",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S1040-8428(02)00159-2",
language = "English",
volume = "46",
pages = "33--57",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Immunology and immunotherapy of colorectal cancer

AU - Dalerba, Piero

AU - Maccalli, Cristina

AU - Casati, Chiara

AU - Castelli, Chiara

AU - Parmiani, Giorgio

PY - 2003/4/1

Y1 - 2003/4/1

N2 - This review critically discusses data on immunology of colorectal cancer, starting from pathology and molecular biology, and then considering the molecular characterisation of colon cancer antigens and the clinical trials of immunotherapy. A careful evaluation of histopathological studies on intra-epithelial infiltration by T cells in primary tumours, together with the analysis of HLA expression by colorectal cancer cells, suggest that anti-tumour T cell immune responses may take place in vivo in those patients, influencing prognosis and shaping the tumour immunological profile. Moreover, the molecular characterisation of tumour antigens expressed by colorectal carcinomas, together with improved understanding of mechanisms of the immune response and more sensitive methods for the in vivo detection of T cell responses, are now allowing researchers to design new and more effective vaccination protocols, with encouraging preliminary results. By drawing together the experimental evidence from different research fields, this review provides support for the concept that colorectal carcinoma is immunogenic and may reasonably be considered as a target for immunotherapy, and attempts to address critical issues and envisage future developments in this challenging research field.

AB - This review critically discusses data on immunology of colorectal cancer, starting from pathology and molecular biology, and then considering the molecular characterisation of colon cancer antigens and the clinical trials of immunotherapy. A careful evaluation of histopathological studies on intra-epithelial infiltration by T cells in primary tumours, together with the analysis of HLA expression by colorectal cancer cells, suggest that anti-tumour T cell immune responses may take place in vivo in those patients, influencing prognosis and shaping the tumour immunological profile. Moreover, the molecular characterisation of tumour antigens expressed by colorectal carcinomas, together with improved understanding of mechanisms of the immune response and more sensitive methods for the in vivo detection of T cell responses, are now allowing researchers to design new and more effective vaccination protocols, with encouraging preliminary results. By drawing together the experimental evidence from different research fields, this review provides support for the concept that colorectal carcinoma is immunogenic and may reasonably be considered as a target for immunotherapy, and attempts to address critical issues and envisage future developments in this challenging research field.

KW - Colorectal cancer

KW - Immunotherapy

KW - T cells

KW - Tumour antigens

KW - Tumour vaccines

UR - http://www.scopus.com/inward/record.url?scp=0037381134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037381134&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(02)00159-2

DO - 10.1016/S1040-8428(02)00159-2

M3 - Article

C2 - 12672517

AN - SCOPUS:0037381134

VL - 46

SP - 33

EP - 57

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1

ER -